Valuation (21%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -58.85 | N/A |
PEG Ratio (TTM) | 0.95 | N/A |
P/S Ratio (TTM) | N/A | N/A |
P/B Ratio (TTM) | 5.73 | N/A |
P/FCF Ratio (TTM) | -373.25 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -6.33% | N/A |
ROE (TTM) | -7.10% | N/A |
Net Profit Margin (TTM) | N/A | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -108.46% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -114.75% | N/A | N/A |
Cash Flow | -67.54% | N/A | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.03 | N/A |
Quick Ratio (TTM) | 0.03 | N/A |
D/E Ratio (TTM) | 0.09 | N/A |
Interest Coverage (TTM) | N/A | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | 5.08 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |